Insider Transactions in Q1 2021 at 1 Life Healthcare Inc (ONEM)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2021
|
David P Kennedy |
SELL
Open market or private sale
|
Indirect |
8,334
-0.97%
|
$333,360
$40.39 P/Share
|
|
Mar 17
2021
|
Kimber D Lockhart Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
30,000
-16.24%
|
$1,230,000
$41.8 P/Share
|
|
Mar 17
2021
|
Kimber D Lockhart Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+23.0%
|
$120,000
$4.36 P/Share
|
|
Mar 05
2021
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
41,066
+12.02%
|
$246,396
$6.13 P/Share
|
|
Mar 03
2021
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
8,332
-8.99%
|
$374,940
$45.32 P/Share
|
|
Mar 03
2021
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
8,332
+14.94%
|
$58,324
$7.77 P/Share
|
|
Mar 03
2021
|
Kimber D Lockhart Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
30,000
-16.23%
|
$1,350,000
$45.12 P/Share
|
|
Mar 03
2021
|
Kimber D Lockhart Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+23.0%
|
$120,000
$4.36 P/Share
|
|
Feb 22
2021
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
4,102
-4.81%
|
$225,610
$55.73 P/Share
|
|
Feb 22
2021
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
4,102
+4.63%
|
$45,122
$11.52 P/Share
|
|
Feb 18
2021
|
David P Kennedy |
SELL
Open market or private sale
|
Indirect |
8,334
-1.4%
|
$458,370
$55.11 P/Share
|
|
Feb 17
2021
|
Kimber D Lockhart Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
30,000
-10.89%
|
$1,650,000
$55.85 P/Share
|
|
Feb 17
2021
|
Kimber D Lockhart Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+23.0%
|
$120,000
$4.36 P/Share
|
|
Feb 03
2021
|
Kimber D Lockhart Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
30,000
-10.69%
|
$1,620,000
$54.41 P/Share
|
|
Feb 03
2021
|
Kimber D Lockhart Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+23.0%
|
$120,000
$4.36 P/Share
|
|
Feb 03
2021
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
8,332
-9.13%
|
$449,928
$54.03 P/Share
|
|
Feb 03
2021
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
8,332
+7.7%
|
$41,660
$5.89 P/Share
|
|
Feb 01
2021
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,610
+31.83%
|
$88,270
$7.93 P/Share
|
|
Jan 21
2021
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
4,102
-3.22%
|
$200,998
$49.98 P/Share
|
|
Jan 21
2021
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
4,102
+4.63%
|
$45,122
$11.52 P/Share
|
|
Jan 20
2021
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,200
-58.39%
|
$1,050,400
$52.5 P/Share
|
|
Jan 20
2021
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,200
+36.86%
|
$141,400
$7.93 P/Share
|
|
Jan 20
2021
|
Kimber D Lockhart Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
30,000
-8.42%
|
$1,560,000
$52.2 P/Share
|
|
Jan 20
2021
|
Kimber D Lockhart Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+12.68%
|
$120,000
$4.37 P/Share
|
|
Jan 19
2021
|
David P Kennedy |
SELL
Open market or private sale
|
Indirect |
8,334
-0.55%
|
$375,030
$45.68 P/Share
|
|
Jan 19
2021
|
Andrew S Diamond Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
75,000
-22.31%
|
$3,300,000
$44.12 P/Share
|
|
Jan 19
2021
|
Andrew S Diamond Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+18.22%
|
$450,000
$6.43 P/Share
|
|
Jan 15
2021
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,200
-29.4%
|
$848,400
$42.57 P/Share
|
|
Jan 15
2021
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,200
+36.86%
|
$141,400
$7.93 P/Share
|
|
Jan 14
2021
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
58,326
-35.75%
|
$2,391,366
$41.43 P/Share
|
|
Jan 14
2021
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
58,326
+26.79%
|
$641,586
$11.52 P/Share
|
|
Jan 14
2021
|
Andrew S Diamond Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
24,375
-9.21%
|
$999,375
$41.2 P/Share
|
|
Jan 14
2021
|
Andrew S Diamond Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,375
+15.45%
|
$97,500
$4.36 P/Share
|
|
Jan 12
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
185,457
-42.65%
|
$7,603,737
$41.23 P/Share
|
|
Jan 12
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
185,457
+29.9%
|
$741,828
$4.01 P/Share
|
|
Jan 12
2021
|
Holmes Kalen |
SELL
Open market or private sale
|
Direct |
31,915
-93.93%
|
$1,308,515
$41.22 P/Share
|
|
Jan 11
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
255,000
-26.55%
|
$10,455,000
$41.85 P/Share
|
|
Jan 11
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
255,000
+33.58%
|
$1,020,000
$4.01 P/Share
|
|
Jan 08
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
156,545
-21.25%
|
$6,574,890
$42.89 P/Share
|
|
Jan 08
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
156,545
+27.83%
|
$626,180
$4.01 P/Share
|
|
Jan 07
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
165,554
-14.91%
|
$6,953,268
$42.72 P/Share
|
|
Jan 07
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
165,554
+28.52%
|
$662,216
$4.01 P/Share
|
|
Jan 06
2021
|
Kimber D Lockhart Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
30,000
-16.23%
|
$1,290,000
$43.14 P/Share
|
|
Jan 06
2021
|
Kimber D Lockhart Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+23.0%
|
$120,000
$4.37 P/Share
|
|
Jan 06
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
208,572
-25.95%
|
$8,968,596
$43.14 P/Share
|
|
Jan 06
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
208,572
+31.29%
|
$834,288
$4.01 P/Share
|
|
Jan 05
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
60,867
-9.82%
|
$2,617,281
$43.15 P/Share
|
|
Jan 05
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
60,867
+16.4%
|
$243,468
$4.01 P/Share
|
|
Jan 04
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
68,005
-5.66%
|
$2,924,215
$43.09 P/Share
|
|
Jan 04
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
68,005
+17.65%
|
$272,020
$4.01 P/Share
|